BPC-157 is one of the most searched research peptides online, and also one of the most misunderstood. Here’s what it actually is, what the research covers, and where the evidence stops.
BPC-157 is a synthetic chain of 15 amino acids — a pentadecapeptide — based on a sequence identified in human gastric juice. “BPC” stands for Body Protection Compound, a name the original research group gave to describe what they set out to investigate, not a conclusion they'd already reached.
Research on the sequence dates back to the early 1990s, originating with a research group studying gut physiology. Since then it has become one of the most published peptides in the "research chemical" category, largely because of one unusual property.
Most peptides break down in minutes when exposed to digestive enzymes and stomach acid. Published reviews describe BPC-157 remaining stable in gastric juice for well beyond 24 hours. That single property is the reason an oral capsule format is viable for this compound at all — it's part of why SenaBio carries an oral version, where most research peptides only make sense as injectables.
The large majority of published work is in rodent models, with study endpoints concentrated on the gastrointestinal tract and on soft-tissue and tendon repair. A 2024 review collected more than 130 published papers on the compound — a substantial body of animal literature.
Human data is a different story. Formal human trials are very limited. Most of what circulates online as "human evidence" is anecdotal, not published clinical research.
The "Wolverine peptide" nickname came from animal tissue-repair studies, amplified by podcasts and forums. It's a marketing shorthand, not a scientific term, and it's worth being skeptical of any source that leans on it instead of the actual research.
Independent testing programs have repeatedly found that a meaningful share of research peptide samples on the market fail on purity, identity, or labelled quantity — most often quantity, where the material is clean but there's simply less of it than the label claims.
A certificate of analysis (COA) from the manufacturer is a starting point, not proof. The only way to know what's actually in a vial or capsule is independent testing after the batch physically arrives — not paperwork produced by the party selling it to you. That's the process we follow for every batch before it's listed; see how we source and test for the full walkthrough.
Oral capsules rely on the acid-stability above. The lyophilised vial is the injectable research format, reconstituted with bacteriostatic water before use.
Freeze-dried peptide is far more stable than reconstituted solution. Keep vials away from heat and direct light; refrigerate once reconstituted rather than leaving it at room temperature.
Body Protection Compound — a descriptive name from the original research group, not a proven effect.
Human trial data is very limited. Most published research is in rodent models.
Testing programs have found research peptide samples that fall short on purity, identity, or quantity. A manufacturer's own paperwork doesn't confirm that independently — third-party testing does.
Keep lyophilised peptide cool, dark, and dry; refrigerate reconstituted solution rather than storing it at room temperature.
Available as oral capsules or a lyophilised vial. Sold by the bottle, not the ten-unit kit.
Shop BPC-157